BRIEF published on 08/15/2024 at 19:00, 1 year 9 months ago CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product International Expansion Medical Cannabis CannapharmaRx Cannabis Production Purchase Orders
PRESS RELEASE published on 08/15/2024 at 18:55, 1 year 9 months ago CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product CannaPharmaRx, Inc. receives 600KG cannabis orders from Cantek Holdings, further solidifying its position in the cannabis market internationally. Continues high-quality production at Cremona facility International Markets CannapharmaRx Cantek Holdings Cannabis Orders Cremona Facility
BRIEF published on 06/28/2024 at 09:05, 1 year 10 months ago CannaPharmaRx Reports Q1 2024 Financial Performance Financial Results Revenue Operating Expenses Licenses Strategic Agreements
PRESS RELEASE published on 06/28/2024 at 09:00, 1 year 10 months ago Q1 2024 Financial Results CannaPharmaRx reports Q1 2024 financial results with revenue commencing. The company anticipates accelerated growth, international expansion, and strategic partnerships Financial Results Revenue Growth Q1 2024 CannapharmaRx
BRIEF published on 05/20/2024 at 19:50, 1 year 11 months ago CannaPharmaRx to Host Investor Conference Call on May 21, 2024 Investor Conference Call Financial Update Cannabis Production Dean Medwid
PRESS RELEASE published on 05/20/2024 at 19:45, 1 year 11 months ago CORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference Call CannaPharmaRx, Inc. (OTC PINK:CPMD) will host an investor conference call on May 21, 2024, at 1PM Eastern time to provide updates on financials, products, distribution, and expansion Investor Conference Call Financial Update CannapharmaRx Cannabis Production CPMD
BRIEF published on 05/20/2024 at 18:35, 1 year 11 months ago CannaPharmaRx to Host Investor Conference Call Investor Conference Financial Update CannapharmaRx Cannabis Production Dean Medwid
PRESS RELEASE published on 05/20/2024 at 18:30, 1 year 11 months ago CannaPharmaRx to Host Investor Conference Call CannaPharmaRx, Inc. to hold investor conference call on May 21, 2024, providing updates on financials, products, orders, and forecasts. Visit www.cannapharmarx.com for details Investor Conference Call Financial Update CannapharmaRx Cannabis Production Forecasted Revenues
BRIEF published on 04/02/2024 at 12:05, 2 years 1 month ago CannapharmaRx Successfully Repays Convertible Notes to Strengthen Position Convertible Notes Debt Repayment Shareholder Interests CannapharmaRx Cannabis Production
PRESS RELEASE published on 04/02/2024 at 12:00, 2 years 1 month ago CannapharmaRx Pays Off Convertible Notes CannapharmaRx, Inc. announces the extinguishment of convertible notes to avoid stock dilution and strengthen the company. CEO Dean Medwid discusses the positive impact on future growth and valuation Convertible Notes Future Growth CannapharmaRx Stock Dilution CEO Dean Medwid
Published on 05/16/2026 at 01:15, 1 day 14 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day 15 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 16 hours ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 1 day 16 hours ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/16/2026 at 16:08, 23 hours 21 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 1 day 19 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 1 day 21 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 17:33, 1 day 21 hours ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 05/15/2026 at 15:08, 2 days ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/13/2026 at 17:45, 3 days 21 hours ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
Published on 05/13/2026 at 17:45, 3 days 21 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026
Published on 05/13/2026 at 17:40, 3 days 21 hours ago Report on share repurchases from 6 to 12 May 2026
